BioSpace News Archive

Business

Bio-Techne Declares Dividend - August 08, 2023

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2023.

August 8, 2023
·
2 min read
Business

ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

ADC Therapeutics SA (NYSE: ADCT) today reported financial results for the second quarter 2023 and provided business updates.

August 8, 2023
·
22 min read
BioMidwest

Monopar Provides Encouraging Camsirubicin Clinical Data Update - August 08, 2023

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer, provided an update from its currently enrolling multi-center open-label Phase 1b clinical trial of camsirubicin in patients with advanced soft tissue sarcoma.

August 8, 2023
·
5 min read
Business

Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported financial results for the second quarter ended June 30, 2023 and provided a corporate update.

August 8, 2023
·
16 min read
Business

Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Crinetics Pharmaceuticals, Inc. reported financial results for the second quarter ended June 30, 2023.

August 8, 2023
·
11 min read
Business

InspireMD Reports Second Quarter 2023 Financial Results and Provides Business Update

InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System for treatment of carotid artery disease and prevention of stroke announced financial and operating results for the second quarter ended June 30, 2023.

August 8, 2023
·
13 min read
Genetown

Bioxytran Initiates a Registrational Trial of Oral ProLectin-M for Mild to Moderate COVID-19 Patients

BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced the initiation of a clinical trial to treat Mild to Moderate COVID-19 patients.

August 8, 2023
·
3 min read
Business

Foghorn Therapeutics Announces Chief Medical Officer Succession

Foghorn ® Therapeutics Inc. today announced that Alfonso Quintás-Cardama, M.D., will join the company as Chief Medical Officer, on September 11, 2023.

August 8, 2023
·
4 min read
Business

Element Biosciences and Agilent Technologies Expand Partnership

Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, announced an expanded commercial partnership with Agilent Technologies to cooperate in selling Element and Agilent products, starting in the United States.

August 8, 2023
·
2 min read
Pharm Country

FesariusTherapeutics receives prestigious NIH SBIR research grant for DermiSphere™ hydrogel technology to treat full thickness skin loss

FesariusTherapeutics, Inc. announced they have been awarded $1.83 Million from the National Institutes of Health to further fund development of their Advanced Dermal Regeneration Scaffold for Reconstructive Surgery.

August 8, 2023
·
3 min read